Real-world use of inhaled nitric oxide therapy in patients with COVID-19 and mild-to-moderate acute respiratory distress syndrome

• Main Authors: Steven H Abman (Author), Nicholas R Fox (Author), M Ibrahim Malik (Author), Sneha S Kelkar (Author), Shelby L Corman (Author), Sanika Rege (Author), Jenna Bhaloo (Author), Rachel Shah (Author), Ren-Jay Shei (Author), Dana Saporito (Author), Nisreen Shamseddine (Author), Erik DeBoer (Author), George J Wan (Author), on behalf of the NOTICE Study Investigators (Author)
• Format: Book
• Published: BioExcel Publishing Ltd, 2022-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Inhaled nitric oxide (iNO) has been studied in patients with severe acute respiratory distress syndrome (ARDS) due to COVID-19 when it may be too late to impact disease course. This article aims to describe real-world iNO use and outcomes in patients with COVID-19 with mild-to-moderate A...